Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cadrenal Therapeutics, Inc. | Chief Medical Officer | Stock Options | 150K | Jan 18, 2024 | Direct | ||
Longeveron Inc. | Director | Stock Option (Right to buy) | 12K | Dec 21, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CVKD | Cadrenal Therapeutics, Inc. | Jan 18, 2024 | 1 | $0 | 4 | Jan 19, 2024 | Chief Medical Officer |
LGVN | Longeveron Inc. | Dec 21, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Director |
CVKD | Cadrenal Therapeutics, Inc. | Jan 19, 2023 | 0 | $0 | 3/A | Mar 31, 2023 | Chief Medical Officer |
LGVN | Longeveron Inc. | Dec 21, 2022 | 1 | $0 | 4 | Dec 22, 2022 | Director |